Chronic inflammation of middle ear cholesteatoma promotes its recurrence via a paracrine mechanism
Abstract Background Cholesteatoma disease is an expanding lesion in the middle ear. Hearing loss and facial paralysis alongside with other intracranial complications are found. No pharmaceutical treatment is available today and recurrence after surgical extraction occurs. We investigated possible TL...
Main Authors: | Matthias Schürmann, Felix Oppel, Senyao Shao, Verena Volland-Thurn, Christian Kaltschmidt, Barbara Kaltschmidt, Lars-Uwe Scholtz, Holger Sudhoff |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-02-01
|
Series: | Cell Communication and Signaling |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12964-020-00690-y |
Similar Items
-
Stem Cell-Induced Inflammation in Cholesteatoma Is Inhibited by the TLR4 Antagonist LPS-RS
by: Matthias Schürmann, et al.
Published: (2020-01-01) -
New classification of EAONO/JOS cholesteatoma and SAMEO-ATO middle ear surgery: relevance and clinical significance
by: Ekaterina V. Pchelenok, et al.
Published: (2021-12-01) -
Postoperative evaluation of recurrence in operated chronic otitis media cases with cholesteatoma
by: Ejder Ciğer, et al.
Published: (2004-09-01) -
Review of potential medical treatments for middle ear cholesteatoma
by: Matthias Schürmann, et al.
Published: (2022-09-01) -
Classification and Stages of Middle Ear Cholesteatoma at the Southern Philippines Medical Center Using the European Academy of Otology and Neurotology / Japan Otological Society (EAONO / JOS) System
by: Dominador Toral, et al.
Published: (2021-05-01)